🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

11 recruiting trials

for Low Grade Glioma of Brain

NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors NCT07664176Phase 11 site📍 Washington D.C. Children's National Research Institute · Tests: NeuroNavigation-Guided Focused Ultrasound (NgFUS), Lumason, Nivolumab Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma NCT07506239NA1 site📍 San Francisco University of California, San Francisco · Tests: Laser Interstitial Thermal Therapy (LITT), Magnetic resonance imaging (MRI), Questionnaires Measure of the Potential Evoked by Electric Stimulation NCT02509442NA1 site📍 Montpellier University Hospital, Montpellier · Tests: Diffusion of direct electric stimulation Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial NCT06132685Phase 21 site📍 Atlanta Emory University · Tests: Biospecimen Collection, Computed Tomography, Dexamethasone, Magnetic Resonance Imaging, Questionnaire Administration SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma NCT04923126Phase 1, Phase 21 site📍 Memphis St. Jude Children's Research Hospital · Tests: Mirdametinib Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG NCT05555550EARLY Phase 11 site📍 Philadelphia Children's Hospital of Philadelphia · Tests: 18F-Fluciclovine ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas NCT05609994Phase 11 site📍 Durham Katy Peters, MD, PhD · Tests: PEPIDH1M vaccine + vorasidenib Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas NCT07110246Phase 212 sites📍 Birmingham📍 San Francisco📍 Washington D.C. University of California, San Francisco · Tests: Dabrafenib, Trametinib, Magnetic Resonance Imaging (MRI), Specimen Collection, Optional Lumbar puncture Patient Voice in the Treatment of Low-grade Gliomas: Use of Patient-reported Outcomes, Vorasidenib and Radiotherapy Compared NCT07547163n/a1 site📍 Milan Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Tests: Vorasidenib, Radiotherapy, active surveillance Longitudinal Analysis of the Health-related Quality of Life in Glioma Patients NCT03849430n/a1 site📍 Leuven Universitaire Ziekenhuizen KU Leuven Window of Opportunity Study of DSP-0390 in Gliomas NCT06636162EARLY Phase 11 site📍 St Louis Washington University School of Medicine · Tests: DSP-0390
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy